HDAC9 and neoplasm: This could be explored using multi-omic analysis of clinically relevant patient-derived models,43 retrospective analysis of tumor samples treated with HDAC inhibitors in previous early-phase clinical trials, and translational analysis of both pre- and on-treatment tumor biopsies during a prospectively conducted HDAC inhibitor clinical trial.